NovaBay Pharmaceuticals, Inc. Short Term Investments Change (Net)

Short Term Investments Change (Net) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Short Term Investments Change (Net) growth rates and interactive chart.


Highlights and Quick Summary

  • Short Term Investments Change (Net) for the quarter ending December 31, 2014 was $1.25 Million (a -50.92% decrease compared to previous quarter)
  • Year-over-year quarterly Short Term Investments Change (Net) decreased by -154.11%
  • Annual Short Term Investments Change (Net) for 2014 was $2.54 Million (a 63.95% increase from previous year)
  • Annual Short Term Investments Change (Net) for 2013 was $1.55 Million (a 2.86% increase from previous year)
  • Annual Short Term Investments Change (Net) for 2012 was $1.51 Million (a -133.11% decrease from previous year)
  • Twelve month Short Term Investments Change (Net) ending December 31, 2014 was $2.54 Million (a -2.94% decrease compared to previous quarter)
  • Twelve month trailing Short Term Investments Change (Net) decreased by -3017.24% year-over-year
Trailing Short Term Investments Change (Net) for the last four month:
31 Dec '14 30 Sep '14 30 Jun '14 31 Mar '14
$2.54 Million $2.62 Million $985 Thousand $-87 Thousand
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Short Term Investments Change (Net) of NovaBay Pharmaceuticals, Inc.

Most recent Short Term Investments Change (Net)of NBY including historical data for past 10 years.

Interactive Chart of Short Term Investments Change (Net) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Short Term Investments Change (Net) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2014 $1.25 $2.55 $1.05 $-2.31 $2.54
2013 $1.33 $0.92 $-0.02 $-0.68 $1.55
2012 $0.52 $1.04 $-0.52 $0.46 $1.51
2011 $-3.53 $-4.55

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology